Care is required with cost effectiveness approach.
Cates
C
C
D000925:Anticoagulants / Q000191:economics*; D001241:Aspirin / Q000191:economics; D001281:Atrial Fibrillation / Q000188:drug therapy*; D003362:Cost-Benefit Analysis; D016527:Drug Costs; D006801:Humans; D020521:Stroke / Q000517:prevention & control*
D000925:Anticoagulants; D001241:Aspirin